TAC1 and fibromyalgia: Patients with fibromyalgia often display heightened levels of Substance P and decreased levels of serotonin, norepinephrine, and dopamine metabolites in their cerebrospinal fluid, indicating altered pain processing and reduced central regulation of sensory information [9].